XML 85 R68.htm IDEA: XBRL DOCUMENT v3.20.4
Earnings Per Share (Details) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 15, 2017
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (116,100,000) $ (74,800,000) $ (205,700,000)  
Less: amounts allocated to participating securities (39,500,000) (35,700,000) (32,400,000)  
Net loss attributable to common stockholders $ (155,600,000) $ (110,500,000) $ (238,100,000)  
Denominator:        
Weighted average common shares outstanding - basic and diluted (shares) [1] 48,776,000 48,280,000 48,028,000  
Basic and diluted loss per share (in USD per share) [1] $ (3.19) $ (2.29) $ (4.96)  
Stock repurchase program, authorized amount       $ 50,000,000.0
Shares repurchased (shares)     156,818  
Shares repurchased, average price per share (in USD per share)     $ 12.64  
Stock repurchase program, remaining authorized repurchase amount $ 46,000,000.0      
Stock options        
Denominator:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 712,000 0 83,000  
Restricted shares        
Denominator:        
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 981,000 67,000 198,000  
[1] The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in those periods.